MIRA Pharmaceuticals, Inc. Common Stock (MIRA) Stock Analysis

MIRA Pharmaceuticals, Inc. Common Stock (MIRA) is a publicly traded company in the HEALTHCARE sector. It trades at $1.04, carries a market capitalization of $44.12M. This page summarizes the public market data, fundamentals, and frequently asked questions for MIRA, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - DRUG MANUFACTURERS - GENERAL

Exchange: NASDAQ

Key Metrics

• Price: $1.04
• Market Cap: $44.12M
• EPS: $-1.27
• 52-Week High: $2.45
• 52-Week Low: $0.90

Market Sentiment

MIRA Pharmaceuticals, Inc. Common Stock currently has a Bullish sentiment score of 0.45.

About MIRA Pharmaceuticals, Inc. Common Stock

MIRA Pharmaceuticals, Inc. is a clinical development stage biopharmaceutical company based in Baltimore, Maryland, specializing in the advancement of innovative therapies for unmet medical needs. With a robust pipeline of proprietary drug candidates undergoing rigorous clinical trials, MIRA aims to enhance treatment outcomes across various therapeutic areas. The company's strong commitment to research and development, coupled with its potential to disrupt the biopharmaceutical landscape, posi...

GNG Research Analysis

GNG Research scores MIRA Pharmaceuticals, Inc. Common Stock (MIRA) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for MIRA.

Frequently Asked Questions

Does MIRA pay dividends?

MIRA Pharmaceuticals, Inc. Common Stock (MIRA) does not currently pay a regular dividend.

What is MIRA's market cap?

MIRA Pharmaceuticals, Inc. Common Stock (MIRA) has a market capitalization of $44.12M with a current stock price of $1.04.